1. Academic Validation
  2. Dual P2Y 12 receptor signaling in thrombin-stimulated platelets--involvement of phosphoinositide 3-kinase beta but not gamma isoform in Ca2+ mobilization and procoagulant activity

Dual P2Y 12 receptor signaling in thrombin-stimulated platelets--involvement of phosphoinositide 3-kinase beta but not gamma isoform in Ca2+ mobilization and procoagulant activity

  • FEBS J. 2008 Jan;275(2):371-85. doi: 10.1111/j.1742-4658.2007.06207.x.
Paola E J van der Meijden 1 Simone M Schoenwaelder Marion A H Feijge Judith M E M Cosemans Imke C A Munnix Reinhard Wetzker Regine Heller Shaun P Jackson Johan W M Heemskerk
Affiliations

Affiliation

  • 1 Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), University of Maastricht, Maastricht, the Netherlands.
Abstract

During thrombus formation, Thrombin, which is abundantly present at sites of vascular injury, activates platelets in part via autocrine-produced ADP. We investigated the signaling pathways by which Thrombin and ADP in synergy induced platelet CA(2+) elevation and procoagulant activity, and we monitored the consequences for the coagulation process. Even at high Thrombin concentration, autocrine and added ADP enhanced and prolonged CA(2+) depletion from internal stores via stimulation of the P2Y(12) receptors. This P2Y(12)-dependent effect was mediated via two distinct signaling pathways. The first is enhanced CA(2+) mobilization by the inositol 1,4,5-trisphosphate receptors due to inhibition of protein kinase A. The second pathway concerns prolonged activation of phosphoinositide 3-kinase (PI3-K) and Phospholipase C. Experiments with phosphoinositide 3-kinase isoform-selective inhibitors and p110gamma deficient platelets demonstrated that the phosphoinositide 3-kinase beta and not the phosphoinositide 3-kinase gamma isoform is responsible for the prolonged CA(2+) response and for the subsequent increases in procoagulant activity and coagulation. Taken together, these results demonstrate a dual P2Y(12)-dependent signaling mechanism, which increases the platelet-activating effect of Thrombin by prolongation of CA(2+) elevation, thereby facilitating the coagulation process.

Figures